2Fossella FV. Docetaxel in the treatment of nonsmall cell lung cancer:review of single-agent trials[J]. Semin Oncol,1999,26(5 Suppl 16):17-23, 41-42.
3Miller VA, Kris MG. Docetaxel( Taxotere ) as a single agent and in combination chemotherapy for the treatment of patients with advanced non-small cell lung cancer[J].Semin Oncol,2000,27( 2 Suppl 3):3-10.
4Perng RP, Shih JF, Chen YM, et al. A phase Ⅱ study of single-agent docetaxel chemotherapy for non-small cell lung cancer [J]. Jpn J Clin Oncol ,2000,30(10):429-434.
5Bonomi P, Mitchell JB, Johnson DH, et al. Nonsmall-cell lung cancer chemotherapy [A]. Lung Cancer [M]. Philadelphia:Lippincott-Raven Publishers,1996.811-824.
6Parkor SL, Tong T, Bolden S Ca. Statistics cancer[J]. Clinic, 1997,47:5-27.
7Kennedy BJ. The snail's pace of lung carcinoma chemotherapy [J]. Cancer, 1998,82(5):801-803.
8Le Chevalier T, Berille J, Zalcberg JR, et al.Overview of docetaxel (taxotere)/cisplatin combination in non-small cell lung cancer[J]. Semin Oncol,1999, 26(3 Suppl 11):13-18.
9Ferlini C, Scambia G, Distefano M, et al. Synergistic antiproliferative activity of tamoxifen and docetaxee on three oestrogen receptor negative cancer cell lines is mediated by the induction of apoptosis[J]. Br J Cancer, 1997,75:884-891.
